Search research articles
Contact Us
Filters
Showing results (81-90 of 1,622) with videos related to
Page
of 163
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2005
Hormonal therapy of endometrial cancer
Maurie Markman
Current Oncology Reports
|
June 11, 2005
Unique issues in the development of "targeted" antineoplastic pharmaceutical agents
Maurie Markman
The Yale Journal of Biology and Medicine
|
November 1, 1991
Taxol: an important new drug in the management of epithelial ovarian cancer
M Markman
Journal of Cancer Research and Clinical Oncology
|
January 1, 1994
The difficulty defining "benefit" of new antineoplastic strategies
M Markman
Journal of Cancer Research and Clinical Oncology
|
January 1, 1993
Report from the Second National Cancer Institute Workshop on Taxol and Taxus. 23-24 September 1992
M Markman
Journal of Cancer Research and Clinical Oncology
|
January 1, 1995
36th annual meeting of the American Society of Hematology. Nashville, 2-6 December 1994
M Markman
Journal of Cancer Research and Clinical Oncology
|
January 1, 1995
26th annual meeting of the Society of Gynecologic Oncologists. San Francisco, 18-22 February 1995
M Markman
Journal of Cancer Research and Clinical Oncology
|
January 1, 1993
Optimal versus maximally tolerated dose in cancer chemotherapy treatment
M Markman
Seminars in Surgical Oncology
|
July 1, 1994
Second-line chemotherapy for refractory cancer: intraperitoneal chemotherapy
M Markman
Lancet (London, England)
|
July 3, 1982
Cholecystectomy and carcinoma of the colon
M Markman
Page
of 163
Search research articles
Search
Showing results (81-90 of 1,622) with videos related to
Sort By:
Page
of 163
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2005
Hormonal therapy of endometrial cancer
Maurie Markman
Current Oncology Reports
|
June 11, 2005
Unique issues in the development of "targeted" antineoplastic pharmaceutical agents
Maurie Markman
The Yale Journal of Biology and Medicine
|
November 1, 1991
Taxol: an important new drug in the management of epithelial ovarian cancer
M Markman
Journal of Cancer Research and Clinical Oncology
|
January 1, 1994
The difficulty defining "benefit" of new antineoplastic strategies
M Markman
Journal of Cancer Research and Clinical Oncology
|
January 1, 1993
Report from the Second National Cancer Institute Workshop on Taxol and Taxus. 23-24 September 1992
M Markman
Journal of Cancer Research and Clinical Oncology
|
January 1, 1995
36th annual meeting of the American Society of Hematology. Nashville, 2-6 December 1994
M Markman
Journal of Cancer Research and Clinical Oncology
|
January 1, 1995
26th annual meeting of the Society of Gynecologic Oncologists. San Francisco, 18-22 February 1995
M Markman
Journal of Cancer Research and Clinical Oncology
|
January 1, 1993
Optimal versus maximally tolerated dose in cancer chemotherapy treatment
M Markman
Seminars in Surgical Oncology
|
July 1, 1994
Second-line chemotherapy for refractory cancer: intraperitoneal chemotherapy
M Markman
Lancet (London, England)
|
July 3, 1982
Cholecystectomy and carcinoma of the colon
M Markman
Page
of 163